Abstract
In the present study, we examined the effect of bexarotene (Targretin) and budesonide in the chemoprevention of small cell lung carcinoma using a lung-specific knockout model of Rb1 and p53. Upon treatment with bexarotene, tumor incidence, number, and load were significantly reduced (P < 0.05). Budesonide treatment trended to inhibition, but the effect was not statistically significant (P > 0.05). Immunohistochemical staining indicated that bexarotene treatment decreased cell proliferation and increased apoptosis in tumors. The Rb1/ p53 gene-targeted mouse seems to be a valuable model for chemopreventive studies on human small cell lung cancer. Our results indicate that the retinoid X receptor agonist bexarotene may be a potent chemopreventive agent in this cancer type.
Original language | English (US) |
---|---|
Pages (from-to) | 1059-1064 |
Number of pages | 6 |
Journal | Cancer Prevention Research |
Volume | 2 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2009 |
ASJC Scopus subject areas
- Oncology
- Cancer Research